GUANABENZ ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Guanabenz Acetate, and when can generic versions of Guanabenz Acetate launch?
Guanabenz Acetate is a drug marketed by Ani Pharms, Chartwell Rx, and Watson Labs. and is included in four NDAs.
The generic ingredient in GUANABENZ ACETATE is guanabenz acetate. There are six drug master file entries for this compound. Additional details are available on the guanabenz acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GUANABENZ ACETATE?
- What are the global sales for GUANABENZ ACETATE?
- What is Average Wholesale Price for GUANABENZ ACETATE?
Summary for GUANABENZ ACETATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 3 |
Patent Applications: | 830 |
DailyMed Link: | GUANABENZ ACETATE at DailyMed |
Recent Clinical Trials for GUANABENZ ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yokohama City University | Phase 2 |
Kathy Miller | N/A |
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 |